| View |
|
BR-735
|
Epoeitin Alfa
|
Hemapo
|
4000 IU/mL
|
Solution for Injection (IV/SC)
|
Prescription Drug (RX)
|
2 mL USP Type I clear, colorless glass vial with grey
flip-off cap and net content of 1 mL (Box of 10's)
|
-
|
Center of Molecular Immunology (CIM)
|
Cuba
|
|
Globo Asiatico Enterprises, Inc.
|
Globo Asiatico Enterprises, Inc.
|
Renewal (Reconstruction)
|
17 June 2022
|
29 October 2024
|
| View |
|
BR-737
|
Diphtheria and Tetanus Vaccine (Adsorbed)
|
SII TD-VAC
|
Formulation: Each dose (0.5 mL) contains: Diphtheria Toxoid.........<5 Lf 2 2 IU) Tetanus Toxoid................<5 Lf( 40 IU) Adsorbed on Aluminum Phosphate, Al3+.....................< 1.25 mg
|
Suspension for Injection (IM)
|
Prescription Drug (RX)
|
Single dose. Ampoule x 0.5 mL (Box of ’s and 50's).
|
-
|
Serum Institute of India Pvt. Ltd.
|
India
|
N/A
|
Medical Vaccines Online Deliveries
|
Medical Vaccines Online Deliveries
|
Renewal
|
02 June 2022
|
27 April 2027
|
| View |
|
BR-738
|
Bevacizumab
|
Avastin
|
100 mg/ 4 mL (25 mg/ mL)
|
Concentrate For Solution For IV Injection
|
Prescription Drug (RX)
|
4 mL Type I Glass Vial (Box of 1's)
|
-
|
Roche Diagnostics GmbH
|
Germany
|
F. Hoffmann
|
Roche (Philippines), Inc.
|
Zuellig Pharma Corporation
|
-
|
08 March 2021
|
09 July 2025
|
| View |
|
BR-739
|
Bevacizumab
|
Avastin
|
400 mg/16 mL (25 mg/mL)
|
Concentrate for Solution
for Infusion (IV)
|
Prescription Drug (RX)
|
Type I glass vial x 16 mL (Box of 1's)
|
-
|
Roche Diagnostics GmbH
|
Germany
|
F.Hoffman-La Roche Ltd.
|
Roche (Philippines) Inc.
|
Zuellig Pharma Corporation
|
-
|
21 January 2022
|
09 July 2025
|
| View |
|
BR-740
|
Somatropin
|
Genheal
|
4 IU (equivalent to 1.6 mg)
|
Lyophilized Powder for
Injection (IM/SC)
|
Prescription Drug (RX)
|
2 mL Type I Glass Vial (Box of 1’s)
|
-
|
Shanghai United Cell Biotechnology Co., Ltd.
|
China
|
N/A
|
Unilab, Inc.
|
Unilab, Inc.
|
Renewal (Revalidation)
|
17 October 2022
|
26 July 2025
|
| View |
|
BR-744
|
Recombinant Hepatitis B Vaccine.
|
Engerix B
|
20 mcg/mL
|
Suspension for Injection (IM)
|
Prescription Drug (Rx)
|
1 mL Pre-filled Syringe + 1 Sterile needle [25G x 1"] (Box of 1's)
|
Vaccines
|
GlaxoSmithKline Biologicals NL DER Smithkline Beecham
Pharma GmbH & Co. KG
|
Germany
|
|
GlaxoSmithKline Philippines, Inc.
|
|
Initial (Variation)
|
22 April 2024
|
22 April 2029
|
| View |
|
BR-745
|
Recombinant Hepatitis B Vaccine
|
Engerix B Junior
|
10 mcg/0.5 mL
|
Suspension for Injection (IM)
|
Prescription Drug (Rx)
|
0.5 mL Pre-filled Syringe + 1 Sterile needle [25G x 5/8"]
(Box of 1's)
|
Vaccines
|
GlaxoSmithKline Biologicals NL DER SmithKline
Beecham Pharma GmbH & Co. KG
|
Germany
|
|
GlaxoSmithKline Philippines, Inc.
|
GlaxoSmithKline Philippines, Inc.
|
Initial (Variation)
|
22 April 2024
|
22 April 2029
|
| View |
|
BR-746
|
Filgastrim
|
Leucogen
|
300mcg/mL
|
Solution For Iv/Sc Injection
|
Prescription Drug (RX)
|
1 ml Type I Clear and Colorless Glass Vial (Box of 10's)
|
-
|
Center for Molecular Immunology (CIM)
|
Cuba
|
Innogene Kalbiotech Pte. Ltd.
|
Globo Asiatico Enterprises, Inc.
|
Globo Asiatico Enterprises, Inc.
|
-
|
17 February 2021
|
04 August 2025
|
| View |
|
BR-747
|
Human Albumin
|
Albiomin
|
20% (200 g/L)
|
Solution for Injection for IV Infusion
|
Prescription Drug (RX)
|
50 mL and 100 mL Clear, Colorless Type II (Ph. Eur)
Soda-Lime Silica Glass Vials with Bromobutyl Rubber Stopper (Type I Ph. Eur) (Box of 1's)
|
-
|
Biotest Pharma GmbH
|
Germany
|
|
EC Zuric Biotherapies, Inc.
|
EC Zuric Biotherapies, Inc.
|
-
|
19 February 2021
|
07 September 2025
|
| View |
BR-749_PI_01.pdf
|
BR-749
|
Thyrotropin Alfa
|
Thyrogen
|
900 mcg
|
Lyophilized Powder For Solution For Im Injection
|
Prescription Drug (RX)
|
Type I clear and colorless glass vial
|
Hormone Replacement Therapy
|
Genzyme Ireland Ltd.
|
Ireland
|
|
Sanofi-Aventis Philippines, Inc.
|
|
Monitored Release (Compliance)
|
02 March 2018
|
02 March 2025
|
| View |
|
BR-750
|
Meningococcal (Groups A,
Polysaccharide Diphtheria Toxoid Conjugate Vaccine
|
Menactra
|
Solution for Injection (IM) (see formulation on the
reverse side)
|
Solution For Im Injection
|
Prescription Drug (RX)
|
0.5mL Glass Vial
|
-
|
Sanofi Pasteur
|
U.S.A.
|
N/A
|
Sanofi Pasteur, Inc.
|
Sanofi Pasteur, Inc.
|
Renewal
|
10 July 2023
|
25 August 2028
|
| View |
|
BR-754
|
Epoetin Alfa
|
Eposino
|
6,000 IU/mL
|
Solution for Injection (IV/SC)
|
Prescription Drug (RX)
|
1 mL pre-filled glass syringe (Box of l's)
|
-
|
Shandong Kexing Bioproducts Co., Ltd.
|
China
|
|
Goodfellow Pharma Corporation
|
|
-
|
11 November 2021
|
18 October 2025
|
| View |
|
BR-755
|
Epoetin Alfa (Recombinant Human Erythropoietin)
|
Eposino
|
2,000 IU/mL
|
Solution for Injection (IV/SC)
|
Prescription Drug (RX)
|
1 ml Pre-filled Glass Syringe (Box of 1's)
|
-
|
Shandong Kexing Bioproducts Co., Ltd.
|
China
|
|
Goodfellow Pharma Corporation
|
Goodfellow Pharma Corporation
|
-
|
08 March 2021
|
18 October 2025
|
| View |
|
BR-756
|
Epoetin alfa
|
Eposino
|
4,000 IU/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (RX)
|
1 mL pre-filled glass syringe (Box of l's)
|
-
|
Shandong Kexing Bioproducts Co., Ltd.
|
China
|
|
Goodfellow Pharma Corporation
|
|
-
|
11 November 2021
|
18 October 2025
|
| View |
|
BR-76
|
Albumin
|
Plasbumin - 25
|
12.5 g/50 mL (25%)
|
Solution for Injection (IV)
|
Prescription Drug (RX)
|
50 mL and 100 mL USP Type II Clear Glass Vial with
White Flip-off Cap(Box of 1's)
|
-
|
Grifols Therapeutics LLC
|
U.S.A.
|
|
GB Distributors Inc.
|
GB Distributors Inc.
|
-
|
12 May 2021
|
09 November 2025
|
| View |
|
BR-774
|
Interferon Beta-1A (Human)
|
Rebif
|
132 mcg (36 million I.U.)/1.5 mL
|
Solution for Injection (SC)
|
Prescription Drug (RX)
|
3 mL Pre-filled Type I Glass Cartridge (with Net Content of 1.5 mL) (Box of 4's)
|
-
|
Merck Serono S.p.A.
|
Italy
|
|
Merck, Inc.
|
|
-
|
18 February 2021
|
03 January 2026
|
| View |
|
BR-775
|
Interferon Beta-1A (Human)
|
Rebif
|
66 mcg (18 million I.U)/1.5 mL
|
Solution For Injection (SC)
|
Prescription Drug (RX)
|
3 mL pre-filled Type I glass cartridge (with net content of 1.5 mL) (Box of 4's)
|
-
|
Merck Serono S.p.A.
|
Italy
|
|
Merck, Inc.
|
|
-
|
08 March 2021
|
03 January 2026
|
| View |
|
BR-776
|
Rotavirus Vaccine (Live, Attenuated)
|
Rotarix
|
1.5 mL
|
Oral Suspension
|
Prescription Drug (RX)
|
3 mL (Net content: 1.5 mL) Sterile polyethylene squeezable tube with nozzle fitted with a tip seal and a tube cap (polypropylene) (Box of l’s and 10's)
|
-
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
N/A
|
GlaxoSmithKline Philippines, Inc.
|
GlaxoSmithKline Philippines, Inc.
|
Renewal
|
23 May 2022
|
18 May 2027
|
| View |
|
BR-779
|
Epoetin Alfa
|
Eposino
|
10,000 IU/mL
|
Solution For Injection (IV/SC)
|
Prescription Drug (Rx)
|
1 mL x Pre-filled Glass Syringe (Box of l's)
|
-
|
Shandong Kexing Bioproducts Co., Ltd.
|
China
|
N/A
|
Goodfellow Pharma Corporation
|
Goodfellow Pharma Corporation
|
Regular Renewal (Revalidation)
|
24 January 2023
|
18 January 2026
|
| View |
|
BR-783
|
Human Papillomavirus Vaccine [Types 16 and 18]
(Recombinant, adjuvanted, adsorbed)
|
Cervarix
|
Formulation: 1 dose (0.5 mL) contains: Human Papillomavirus type 16 Ll protein*..............20 mcg Human Papillomavirus type 18 L1 protein*... ...........20 mcg
*adjuvanted by AS04 containing 3-O-desacyl-4-monophosphoryl lipid A (MPL) and Aluminum hydroxide, hydrated [Al(OH)3]
|
Suspension for Injection (IM)
|
Prescription Drug (RX)
|
0.5 mL in 3 mL Type I glass vial (Box of 10's and 100's)
|
-
|
GlaxoSmithKline Biologicals SA
|
Belgium
|
N/A
|
GlaxoSmithKline Philippines, Inc.
|
GlaxoSmithKline Philippines, Inc.
|
-
|
27 April 2022
|
23 March 2027
|